First Time Loading...
M

Mangoceuticals Inc
NASDAQ:MGRX

Watchlist Manager
Mangoceuticals Inc
NASDAQ:MGRX
Watchlist
Price: 0.2631 USD -5.12% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

MGRX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. [ Read More ]

The intrinsic value of one MGRX stock under the Base Case scenario is 0.0251 USD. Compared to the current market price of 0.2631 USD, Mangoceuticals Inc is Overvalued by 90%.

Key Points:
MGRX Intrinsic Value
Base Case
0.0251 USD
Overvaluation 90%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Mangoceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MGRX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Mangoceuticals Inc

Provide an overview of the primary business activities
of Mangoceuticals Inc.

What unique competitive advantages
does Mangoceuticals Inc hold over its rivals?

What risks and challenges
does Mangoceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Mangoceuticals Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mangoceuticals Inc.

Provide P/S
for Mangoceuticals Inc.

Provide P/E
for Mangoceuticals Inc.

Provide P/OCF
for Mangoceuticals Inc.

Provide P/FCFE
for Mangoceuticals Inc.

Provide P/B
for Mangoceuticals Inc.

Provide EV/S
for Mangoceuticals Inc.

Provide EV/GP
for Mangoceuticals Inc.

Provide EV/EBITDA
for Mangoceuticals Inc.

Provide EV/EBIT
for Mangoceuticals Inc.

Provide EV/OCF
for Mangoceuticals Inc.

Provide EV/FCFF
for Mangoceuticals Inc.

Provide EV/IC
for Mangoceuticals Inc.

Compare the intrinsic valuations
of Mangoceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mangoceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mangoceuticals Inc compared to its peers.

Compare the P/E ratios
of Mangoceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Mangoceuticals Inc with its peers.

Analyze the financial leverage
of Mangoceuticals Inc compared to its main competitors.

Show all profitability ratios
for Mangoceuticals Inc.

Provide ROE
for Mangoceuticals Inc.

Provide ROA
for Mangoceuticals Inc.

Provide ROIC
for Mangoceuticals Inc.

Provide ROCE
for Mangoceuticals Inc.

Provide Gross Margin
for Mangoceuticals Inc.

Provide Operating Margin
for Mangoceuticals Inc.

Provide Net Margin
for Mangoceuticals Inc.

Provide FCF Margin
for Mangoceuticals Inc.

Show all solvency ratios
for Mangoceuticals Inc.

Provide D/E Ratio
for Mangoceuticals Inc.

Provide D/A Ratio
for Mangoceuticals Inc.

Provide Interest Coverage Ratio
for Mangoceuticals Inc.

Provide Altman Z-Score Ratio
for Mangoceuticals Inc.

Provide Quick Ratio
for Mangoceuticals Inc.

Provide Current Ratio
for Mangoceuticals Inc.

Provide Cash Ratio
for Mangoceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Mangoceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Mangoceuticals Inc?

What is the current Free Cash Flow
of Mangoceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mangoceuticals Inc.

Financials

Balance Sheet Decomposition
Mangoceuticals Inc

Current Assets 818.5k
Cash & Short-Term Investments 739k
Other Current Assets 79.5k
Non-Current Assets 232.3k
PP&E 215.4k
Other Non-Current Assets 16.9k
Current Liabilities 211.1k
Accounts Payable 140.8k
Accrued Liabilities 70.3k
Non-Current Liabilities 65k
Other Non-Current Liabilities 65k
Efficiency

Earnings Waterfall
Mangoceuticals Inc

Revenue
731.5k USD
Cost of Revenue
-300k USD
Gross Profit
431.5k USD
Operating Expenses
-9.7m USD
Operating Income
-9.2m USD
Other Expenses
6.5k USD
Net Income
-9.2m USD

Free Cash Flow Analysis
Mangoceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MGRX Profitability Score
Profitability Due Diligence

Mangoceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Mangoceuticals Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

MGRX Solvency Score
Solvency Due Diligence

Mangoceuticals Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Mangoceuticals Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MGRX Price Targets Summary
Mangoceuticals Inc

There are no price targets for MGRX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

MGRX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

MGRX Price
Mangoceuticals Inc

1M 1M
+21%
6M 6M
-63%
1Y 1Y
-76%
3Y 3Y
-93%
5Y 5Y
-93%
10Y 10Y
-93%
Annual Price Range
0.2631
52w Low
0.1494
52w High
1.88
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -96%
Shares Statistics
Market Capitalization 6.5m USD
Shares Outstanding 24 619 500
Percentage of Shares Shorted 5.25%

MGRX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Mangoceuticals Inc

Country

United States of America

Industry

Retail

Market Cap

6.5m USD

Dividend Yield

0%

Description

Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.

Contact

TEXAS
Dallas
4131 N Central Expy, Ste 900
+18336264679
https://www.mangorx.com/

IPO

2023-03-21

Employees

-

Officers

CEO & Chairman
Mr. Jacob D. Cohen
President, Secretary & Director
Mr. Jonathan Arango
Chief Financial Officer
Mr. Eugene M. Johnston
Chief Operating Officer
Ms. Amanda Elizabeth Hammer

See Also

Discover More
What is the Intrinsic Value of one MGRX stock?

The intrinsic value of one MGRX stock under the Base Case scenario is 0.0251 USD.

Is MGRX stock undervalued or overvalued?

Compared to the current market price of 0.2631 USD, Mangoceuticals Inc is Overvalued by 90%.